vTv Therapeutics Inc. filed its 10-K on Mar 06, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.58 USD | -3.83% |
|
-0.45% | +52.87% |
Jul. 01 | VTv Therapeutics Inc.(NasdaqCM:VTVT) added to Russell 3000E Index | CI |
Jul. 01 | VTv Therapeutics Inc.(NasdaqCM:VTVT) added to Russell Microcap Index | CI |
1st Jan change | Capi. | |
---|---|---|
+52.87% | 42.77M | |
+16.61% | 122B | |
+17.75% | 112B | |
+18.60% | 25.91B | |
-24.11% | 19.33B | |
-17.94% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- VTv Therapeutics Inc. Auditor Raises 'Going Concern' Doubt